1-3 of 3
Erik J Asmus
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Fixed Duration Therapy with Daratumumab, Carfilzomib, Lenalidomide and Dexamethasone for High Risk Smoldering Multiple Myeloma-Results of the Ascent Trial

Shaji K Kumar, Melissa Alsina, Betsy Laplant, Ashraf Z. Badros, Al-Ola Abdallah, Rafat Abonour, Erik J Asmus, Binod Dhakal, Cara A. Rosenbaum, Daniel Egan, Manisha Bhutani, Andrzej Jakubowiak, Brian G.M. Durie
Journal: Blood
Blood (2022) 140 (Supplement 1): 1830–1832.
https://doi.org/10.1182/blood-2022-168930
Published: 2022
Journal Articles

Fixed Duration Daratumumab, Ixazomib, Lenalidomide, and Dexamethasone Quadruplet for Newly Diagnosed Multiple Myeloma - MRD Negativity and Survival Outcomes

Shaji K Kumar, Betsy Laplant, Erik J Asmus, Francis K. Buadi, Wilson I. Gonsalves, Eli Muchtar, David Dingli, Melanie Ann Thompson, Ronald Go, Rahma M Warsame, Taxiarchis Kourelis, Yi L. Hwa, Amie Fonder, Miriam A. Hobbs, Martha Q. Lacy, Angela Dispenzieri, Suzanne R. Hayman, Nelson Leung, Moritz Binder, S. Vincent Rajkumar, Morie A Gertz, Prashant Kapoor
Journal: Blood
Blood (2022) 140 (Supplement 1): 10142–10143.
https://doi.org/10.1182/blood-2022-169046
Published: 2022
Journal Articles

PD-1 Blockade with Pembrolizumab in Relapsed Low Grade Non-Hodgkin Lymphoma

Wei Ding, MD PhD, Betsy Laplant, MS, Thomas E Witzig, MD, Patrick B Johnston, MD PhD, Joseph P Colgan, MD, Karen L Rech, MD, Jose F. Leis, MD PhD, Andrew L Feldman, MD, Rong He, MD, Grzegorz S Nowakowski, MD, Erik J Asmus, David J Inwards, MD, Luis Porrata, MD, Thomas M Habermann, MD, Yi Lin, MD PhD, Gita Thanarajasingam, MD, Nabila Nora Bennani, MD, Craig B. Reeder, MD, Donald Northfelt, MD, Jeanne Palmer, MD, Prashant Kapoor, MD, David S Viswanatha, MD, Stephen M Ansell, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4055.
https://doi.org/10.1182/blood.V130.Suppl_1.4055.4055
Published: 2017